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Schinus lentiscifolius (Anacardiaceae) is widely used in folk medicine for treating gastrointestinal and
emotional complaints but there are no scientific studies that support these uses. This work aims at
evaluating the antispasmodic and central effects of S. lentiscifolius as well as the flavonoids presence in
the tincture (SchT) and the composition of the essential oil (SchO). SchT inhibited the concentration-
response curves (CRC) of carbachol and calcium in a non-competitive way in isolated rat intestine,
bladder and uterus. SchT also non-competitively inhibited the CRC of histamine in guinea-pig intestine
and the CRCs of serotonin and oxytocin in rat uterus. Isoquercetin and rutin were identified in SchT. The
behavioral effects of SchT, SchO and infusion of S. lentiscifolius leaves (SchW) were tested in mice. These
extracts showed an anxiolytic-like effect in the novelty-suppressed feeding test, which was reversed by
flumazenil except in SchO-treated mice. Only SchO reduced the spontaneous locomotor function in the
open field test. Also, SchT and SchW decreased immobility time in both, the tail suspension (TST) and
forced swimming tests, while SchO produced the same effect in the TST. D-limonene and a-santalol were
the main components found in SchO. The results demonstrated that extracts obtained from
S. lentiscifolius leaves were effective as intestinal, urinary and uterine antispasmodics. SchT and SchW
exhibited anxiolytic and antidepressant properties without sedation, whereas SchO showed also sedative
properties. Therefore, the present study gives preclinical support to the traditional use of this plant for
gastrointestinal and depressive or emotional symptoms.
© 2021 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Schinus lentiscifolius (Anacardiaceae), a native species of South
American popularly known as ‘ashen molle’, is an aromatic, orna-
mental and flowering small tree. This plant is widely used in folk
medicine to treat several diseases incluiding gastrointestinal and, Departamento de Ciencias
acional de La Plata, 47 y 115
(M.I. Ragone).
for Food and Biomolecules,
National Taiwan University. Produc
es/by-nc-nd/4.0/).
e, S. Matera, M. Bayley et al.,
al of Traditional and Complecentral disorders.28
There are some reports about antispasmodic and central anti-
depressant activities of other species of Schinus, such as
S. terebinthifolius Raddi or S. molle Hort.31,41 Often consumers
confuse them; however, despite being morphologically different,
they have similar traditional medicinal applications.28 Similarly,
there is only sufficient evidence about the antifungal, antimicrobial
and antioxidant properties of S. lentiscifolius,20 but there are no
scientific studies that support other uses as antispasmodic and
emotional symptoms.
Phytochemical studies of S. lentiscifolius have resulted in the
isolation of natural mono- and sesquiterpenes, triterpenes,
phenolic compounds, essential oil and flavonoids such astion and hosting by Elsevier Taiwan LLC. This is an open access article under the CC









SchT tincture of Schinus lentiscifolius
SchW infusion of Schinus lentiscifolius
SchO essential oil of Schinus lentiscifolius
IC50 50 % inhibitory concentration
HPLC-UV high-performance liquid chromatography with
ultraviolet detection
GC-FID-MS gas chromatography with flame ionization and
mass spectrometry detectors
OFT open field test
NFT novelty-suppressed feeding test
TST tail suspension test
FST forced swimming test
FL feed latency
IT immobility time
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not only on the central nervous system but also on smooth mus-
cle.21,24 Preliminary flavonoid characterization suggested the
presence of rutin and isoquercetin in the tincture of
S. lentiscifolius.44 Both of them have been demonstrated to be sed-
atives while rutin also showed antidepressant action24 Besides,
their spasmolytic activity has been reported in isolated intestine.22
These reports allow us to hypothesize that S. lentiscifolius could
exert antispasmodic, antidepressant and anxiolytic-like effects, at
least in part due to the presence of flavonoids in the extracts.
On the other hand, the composition of the essential oil of Uru-
guayan and Brazilian specimens of S. lentiscifolius has been
described previously, finding some differences between them.33 As
it happens with other plants, it seems that the variability in the
main components of the essential oil is closely related to the
geographical location of the tested specimen.6 Therefore, the
essential oil of the Argentine S. lentiscifolius may have a different
composition, which would confer other biological activities and it
was considered necessary to evaluate it, since there are no biblio-
graphic data.
Due to the lack of information on the pharmacological potential
and chemical components of S. lentiscifolius, this work evaluates the
antispasmodic and central effects of this plant extracts, as well as
the presence of rutin and isoquercetin in the tincture.Moreover, the
composition of the essential oil obtained from S. lentiscifolius leaves
was analyzed, and it was evaluated in models of anxiety and
depression in mice for comparing with the ethanolic and aqueous
extracts.
2. Materials and methods
2.1. Plant material and extracts preparation
Fresh leaves of S. lentiscifolius were collected from the “Carlos
Spegazzini” Botanical Garden and Arboretum, School of Agricul-
tural and Forestry Sciences of the National University of La Plata in
spring. Plant material was identified by Marta Colares, MSc.
The S. lentiscifolius tincture (SchT) was prepared by 20 % w/v
maceration of leaves in 70 % v/v ethanol fromwhich dilutions were2
made (yield of 10.0 % w/w). The infusion of S. lentiscifolius leaves
(SchW) was prepared at 20 % w/v. The essential oil of leaves of
S. lentiscifolius (SchO) was obtained by hydrodistillation (density of
0.9221 g/ml) according to the Argentine National Pharmacopoeia
(National Formulary method, XIV, 1975). For the biological studies,
it was diluted in dimethyl sulfoxide (DMSO).
Concentration and doses of SChT, SchW and SchO were
expressed as mass of dry leaves by ml or kg, respectively.
2.2. Chromatographic analysis
SchT was analyzed by high-performance liquid chromatography
with ultraviolet detection (HPLC-UV) using a Dionex UltiMate 3000
UHPLC (Thermo Scientific, Sunnyvale, CA, USA) configured with a
dual ternary gradient pump (DGP-3000) and a DAD-3000 diode
array detector (DAD). The stationary phase was a C18 column
(250  4.6 mm, LiChrospher 5 mm, Merck, USA) and the mobile
phase was a 85:10:5 mixture of water:tetrahydrofuran:methanol
adjusted to pH ¼ 2.5 with phosphoric acid with a flow of 1 ml/min.
Detection was performed at 330 nm. The extracts were diluted 1:5
with mobile phase. Reference standard solutions of isoquercetin
and rutin were diluted in methanol and then prepared in mobile
phase at 20 and 10 mg/ml, respectively. Chromatography peaks
were confirmed by comparing their retention time and DAD spectra
(200e400 nm) with those of the standard sample.
2.3. Analysis of the essential oil
The essential oils of S. lentiscifolius leaves was carried out on a
GC-FID-MS system (PerkinElmer Clarus 500) with one injector
(split ratio 1:100) connected by a flow splitter to two capillary
columns (60 m  0.25 mm id and 25 mm stationary phase thick-
ness): (a) polyethylene glycol MW ~20,000 (DB-Wax, J&W Scien-
tific) and (b) 5 % phenyl-95 %methyl silicone. The polar columnwas
connected to a flame ionization detector (FID), while the nonpolar
column was connected to an FID and a quadrupole mass detector
(70 eV) by a vent system (MSVent®). Helium was used as mobile
phase at a constant flow of 1.87 ml/min (split ratio 1:100). The
temperature was programmed according to the following gradient:
90e225 C at 3 C/min, and then isothermal for 15min. The injector
and FID were set at 255 C and 275 C, respectively. The tempera-
tures of the transference line and the ion source were 180 C and
150 C, respectively. The range of masses analyzed was 40e300 Da
(10 scan/s). Identification of the compounds in the SchO was per-
formed by comparison of the linear retention indices (relative to a
homologous series of alkanes [C8eC20]) on both columns with
those of reference compounds. Additionally, each mass spectrum
obtained was compared with those fromwidely used mass spectral
databases39 and mass spectra obtained from reference compounds.
The relative percentage contribution of the compounds was
calculated from the FID responses by computerized integration,
without considering corrections for response factors. The lowest




In order to study the pharmacological activities of
S. lentiscifolius, male and female Wistar rats (200e250 g), male
Swiss mice (25e30 g) and female guinea pigs (280e300 g) were
used. The animals were cared for according to international stan-
dards established by US guidelines (NIH publication #85-23,
revised in 1996) and the principles in the Declaration of Helsinki. A
local ethical committee of the School of Exact Sciences of the
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and D-01-15-16). Rats and guinea pigs were deprived of food but
allowed water ad libitum 12 h before the ex vivo experiments
(isolated tissues), while the mice were only kept fasting for 24 h for
the novelty-suppressed feeding test (NFT).
2.4.2. Isolation of smooth muscles preparations and contractile
measurements
Wistar rats (200e250 g) were anesthetized with urethane
(doses of 1.5 g/kg) after 12 h of fasting. Portions of the rat or guinea
pig intestine and the rat urinary bladder were excised andmounted
in organ baths containing constantly oxygenated Tyrode's solution
(20 ml, pH 8.2) at 37 C.19,35 The uteri of rats were isolated and
immersed in de Jalon's solution at 32 C, bubbled with air.19 All
tissues were equilibrated for 35 min at 1 g of preload. Intestinal
muscle and bladder strips were connected to isometric transducers
(WPI, USA) and the contractile signals were amplified and recorded
with Eagle software (USA). The contractility of the uterus was
detected by PanLabMLT0210/A isometric transducers and recorded
with a PowerLab 2/26 system with LabChart software (ADInstru-
ments, Australia).
2.4.3. Concentration-response curves (CRCs) with carbachol,
serotonin, histamine or oxytocin
CRCs of agonist carbachol (CCh-CRC) were performed on rat
duodenum or ileum, bladder and uterus by cumulatively adding
CCh to the bath within a range of concentrations from 0.01 to 10 mg/
ml up to a maximal contraction. Similarly, a CRC of histamine (His-
CRC; range 1e200 mg/ml) was performed on isolated guinea-pig
ileum, whereas CRCs of oxytocin (Oxt-CRC; range 1e200 mg/ml)
and serotonin (5-HT-CRC; range 0.01e3 mg/ml) were performed on
rat uterus. First, control curves were obtained in the absence
(control condition) and in the presence of vehicle (control vehicle,
70 % v/v ethanol) for comparison with the respective SchT con-
centration. Curves made in the presence of vehicle did not show
differences in the contractile effect compared to control conditions.
SchT (range 0.1e20 mg/ml) were added individually to the medium
5 min before the corresponding CRC. The contractile effects were
expressed as percentage of the maximal tissue contraction (%
Emax), obtained with the control vehicle CRC.
2.4.4. Concentration-response curves with CaCl2 (Ca
2þ-CRC)
Ca2þ-CRCs were performed on intestinal, bladder and uterine
smooth muscle by cumulatively adding CaCl2 (range
0.0195e17.5 mmol/L). After the stabilization period, Ca2þ was
removed from the medium and then the tissues were depolarized
with 40 mmol/L of KCl. There were no differences in the contractile
effect in the presence or absence of vehicle. Each SchT concentra-
tion was added to the bath 5 min before the Ca2þ-CRC. The % Emax
was measured with the same approach previously described.
2.4.5. Pharmacological parameters of CRC
From the CRCs, the pEC50 of the agonist were calculated as log
EC50, in mol/L. For the tincture, the 50 % inhibitory concentration
(IC50) was obtained by extrapolation at 50 % effect of the individual
inhibitory curves at the maximal effect of the agonist.19 IC50 values
of SchT were expressed as mg/ml.
2.4.6. Behavior studies in mice
All drugs were administered by intraperitoneal (i.p.) injections
to mice in a volume of 0.1 ml per 30 g of body weight. The SchT
doses used in the behavioral tests (30 and 100 mg/kg) were
selected according to the concentrations that were effective as
antispasmodics in the CRCs, as scaled from plasmatic level. By other
side, higher doses of SchW (200 and 400 mg/kg) were chosen3
because the content of flavonoids should be lower in the aqueous
than in the ethanolic extracts.14 In both cases, ranges of similar
doses showed to be effective in behavior studies in other medicinal
plants.17,38 Moreover, the SchO doses (10 and 30 mg/kg) used are in
the range of those reported as active for S. terebinthifolius in
memory deficits studies.42
2.4.6.1. Open field test (OFT). Spontaneous locomotor, exploratory
and emotionality activities were evaluated by using the OFT, which
consisted of a white enclosure of 30  50 cm divided into 15
squares of 10 cm2 by black lines surrounded by walls that were
27 cm high. Adequate environmental conditions were main-
tained.11 Prior to treatment, each animal was placed in the same
corner of the open field, allowing free exploration for 5 min. The
test was performed 30 min after the injection of extracts or vehicle,
with diazepam (1 mg/kg), a known benzodiazepine, as reference
compound. During a 5-min period, the number of crossed lines,
rearings, grooming and other signs were measured. The same
protocol was repeated at 60, 90 and 120 min after administration.
2.4.6.2. Novelty-suppressed feeding test (NFT). Mice were placed in
individual cages, being allowed to remain for 30 min to habituate.
After 1 h of extract i.p. administration, each animal was placed in
the same corner of a 40  40  30 cm wooden box containing a
white circular filter paper with a diameter of 11 cm and a single
food pellet in the center. The latency time to start eating was
recorded. Immediately after the first bite, each mouse was removed
and placed in its individual cage with a previously weighed pellet;
after 5 min the amount of food consumed was determined. Finally,
the mice were removed to their home cage with water and food ad
libitum.25 Diazepam (Dzp, 0.3 mg/kg) and flumazenil (Fzl, 0.5 mg/
kg), a benzodiazepine antagonist, were used as reference
compounds.
2.4.6.3. Tail suspension test (TST). TST protocol was previously
described.40 In order to test the Schinus extracts, a structure 50 cm
high, 12 cm deep and 60 cm wide was used. The mice were sus-
pended 50 cm above the ground with adhesive tape placed 2 cm
from the base of their tails in identical individual compartments.
The measurement was performed 1 h after i.p. administration.
Immobility was defined as the permanence in a vertical position
and the lack of any attempt at movement of the hind legs during
suspension and the immobility time (IT, sec) was video recorded for
6 min. Clomipramine (1.25 mg/kg) a known antidepressant, was
used as a reference compound.
2.4.6.4. Forced swimming test (FST). FST protocol was previously
described.45 Swiss mice were injected via i.p. An hour later, they
were introduced into a transparent glass cylinder (diameter: 24 cm;
height: 22 cm) with 10 cm of water at 22e25 C for 6min and the IT
was recorded during the final 4 min. It was considered immobility
when the mouse floated without movement of the hind legs or
made only the movements necessary to keep its head above the
water. At the end of the test, the mice were removed to a dry,
heated place. The bath water was changed after every session to
avoid influence on the next mouse. Clomipramine (1.25mg/kg) was
used as a reference compound.
2.4.7. Drugs and solution
Composition medium and solution used for CRC and the drugs
employed in the biological tests are described in Appendix A.
2.4.8. Statistical analysis
Results are expressed as the mean ± SEM (standard deviation of
the mean), n (number of experiments). Multiple comparisons were
Table 1
Relative percentage composition of the essential oils obtained from leaves of Schinus
lentiscifolius.
Components % Components %
cis-3-hexenol tr a -humulene 0.9
a -pinene 2.4 alloaromadendrene 2.5
Camphene tr trans-cadina-1 (6),4-diene 1.7
methyl heptenone tr l-muurolene 0.2
a -terpinene 0.1 germacrene d 0.1
p-cymen tr epi-bicyclosesquiphellandrene 1.7
Sabinene 1.4 cadina-3,5-diene 1.7
D-limonene 12.9 bicyclogermacrene 1.4
1,8-cineole 0.1 a -muurolene 2.6
l -terpinene 0.1 d -cadinene 21
Terpinolene tr zonarene 0.9
Linalool tr trans-cadina-1,4-diene 1.4
terpinen-4-ol 0.3 a -calacorene 0.2
a -terpineol 0.3 b -calacorene 0.3
Bicycloelemene 0.1 spathulenol 4.1
a -cubebene 1.2 Oxy- caryophyllene 0.9
a- longipinene 0.1 copaborneol 1
Cyclosativene 0.2 1-epi-cubenol 4.7
a -copaene 4.4 globulol 0.2
b -bourbonene 0.1 ledol tr
b -cubebene 0.4 ϯ-muurolol 0.6
a-gurjunene 0.1 a-cadinol 0.2
b -caryophyllene 2.7 mustakona 0.4
l -maaliene tr cetyl alcohol 0.1
guaia-6,9-diene 0.1 isocalamendiol 0.2
b -copaene 0.1 trans phytol 0.1
Aromadendrene 0.2 hydrocarbon 25 0.1
TOTAL 76.5
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appropriate. A posteriori Tukey's test was used. Statistical analyses
were carried out with Graph Pad Prism 8.0 software. P < 0.05 was
considered significant in all tests performed.
3. Results
3.1. Identification of components in S. lentiscifolius tincture
Fig. 1a shows the chromatograms of SchT by HPLC. We found
two peaks with retention times of 45 and 55 min, corresponding to
the reference substances rutin (peak #1) and isoquercetin (peak
#2), respectively. The UV spectra (Fig. 1b) matched the typical
flavonoid spectra.43
3.2. Composition of the essential oil of S. lentiscifolius
Table 1 shows the relative percentage composition of SchO,
whose yield was 1.2 % v/w (ml of essence/100 gr of dried leaves).
3.3. Antispasmodic effects of S. lentiscifolius tincture on smooth
muscle
In the intestinal muscle, SchT reduced significantly the
maximum contractile effect of the CCh-CRC (pEC50 ¼ 6.17 ± 0.16) in
a concentration-dependent way (Fig. 2a). This effect showed a
typical non-competitive antagonism on the cholinergic contraction
with an IC50 of 6.32 ± 1.2 mg SchT/ml. In bladder and uterusmuscle,
SchT also inhibited the CCh-CRC (pEC50 ¼ 6.47 ± 0.08 and
pEC50 ¼ 5.88 ± 0.10, respectively) with a non-competitive pattern
(Fig. 2c and e). The IC50 was 2.63 ± 0.12 mg of SchT/ml in bladder
and 4.05 ± 1.03 mg of SchT/ml in uterus.Fig. 1. High-performance liquid chromatography. Profiles of SchT an
4
To evaluate whether the antispasmodic effects of SchT were due
to inhibition of calcium influx, these effects were assessed on Ca2þ-d standard Solution (a); UV spectra of the identified peaks (b).
Fig. 2. Effects of SchT on the concentration-response curves (CRCs) of carbachol and CaCl2 in isolated rat intestine (a, b), bladder (c, d) and uterus (e, f). Two-way ANOVA: P < 0.001
(Table A3) for both treatment and log [agonist] factors. A posteriori Tukey's test: *p < 0.05 vs control vehicle. (n ¼ 6 in all groups).
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Fig. 3. Effects of SchT on the concentration-response curves (CRCs) of histamine (His)
in isolated guinea-pig ileum (a; n ¼ 6), serotonin (5-HT) (b; n ¼ 4) and oxytocin (Oxt)
in isolated rat uterus (c; n ¼ 5). Two-way ANOVA: P < 0.001 (Table A4) for both
treatment and log [agonist] factors. A posteriori Tukey's test: *p < 0.05 vs control
vehicle.
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of Ca2þ influx (Fig. 2b, d and f in intestinal, bladder and uterine
muscle, respectively). In the intestinal muscle Ca2þ-CRC’s (pEC50 of
2.64 ± 0.12) SchT exhibited an IC50 of 1.90 ± 0.64 mg SchT/ml. In the
bladder and uterine muscles Ca2þ-CRC’s (pEC50 of 2.70 ± 0.06 and
2.76 ± 0.08, respectively), SchT showed IC50 of 2.14 ± 0.10 and
4.20 ± 0.56 mg SchT/ml, respectively.
In addition, SchT was evaluated in the His-CRC in guinea-pig
ileum SchT also inhibited the His-CRC (pEC50 of 5.79 ± 0.18) as a
non-competitive antagonist (Fig. 3a), with an IC50 value of
5.91 ± 0.36 mg SchT/ml.
Moreover, in rat uterus SchT was evaluated in the 5-HT-CRC
(pEC50 of 5.79 ± 0.18) and Oxt-CRC (pEC50 of 5.52 ± 0.06) (Fig. 3b
and c). SchT showed a non-competitive antagonism on both, 5-HT-
CRC and Oxt-CRC, with IC50 of 5.55 ± 0.28 and 2.10 ± 0.09 mg SchT/
ml, respectively.
3.4. Anxiolytic and sedative effects of extracts of S. lentiscifolius on
mice
Three different extracts of S. lentiscifolius (SchT, SchWand SchO)
were tested in the OFT to evaluate their effects. Neither SchT nor
SchW markedly affected the spontaneous locomotion of mice
measured as the number of crossed lines in 5 min (LC) compared to
their respective vehicles. In contrast, both doses of SchO (10 and
30 mg/kg) strongly decreased LC with respect to the vehicle and in a
similar way to diazepam (Dzp, Table 2). Simultaneously, the
exploratory behavior was measured as the number of rearings in
5 min (RE). All extracts decreased RE similarly to Dzp (Table A1).
There were no significant differences in the number of grooming
bouts (Table A2).
In order to evaluate whether S. lentiscifolius induced anxiolytic
effect, the extracts were tested by the NFT. Doses of 30 mg/kg of
SchT or 200 mg/kg of SchW did not change feeding latency (FL) in
NFT compared to their respective vehicles. In contrast, the admin-
istration of 100 mg/kg of SchT or 400 mg/kg of SchW significantly
reduced FL, similarly to Dzp. The decrease in FL induced by higher
doses of SchW and SchT was reversed with flumazenil (Fzl, Fig. 4a
and b). The flavonoid rutin also decreased FL (Fig. 4a). SchO 30 mg/
kg also significantly decreased FL but its effects were not reversed
with Fzl (Fig. 4c). Moreover, only in mice treated with SchO did the
home-cage food consumption decrease (Fig. A2).
3.5. Antidepressant effects of extracts of S. lentiscifolius on mice
The antidepressant effects of Schinus extracts were evaluated
using TST and FST. In TST, the IT was only significantly reduced in
the mice treated with higher doses of each extract with a similar
effect to clomipramine (Fig. 5). Based on these results, SchT
(100 mg/kg), SchW (400mg/kg) and SchO (30 mg/kg) were tested in
mice exposed to FST. Similarly, IT of mice treated with 400mg/kg of
SchW in FST was significantly lower than in saline group and
similar to clomipramine results. On the other hand, 100 mg/kg of
SchT decreased the IT compared to the ethanolic vehicle, but it was
higher than the positive control (Fig. 6). Mice treated with SchO
required rescue in the FST. The shorter IT in both tests suggests
antidepressant effects.
4. Discussion
This is the first time a study provides scientific evidence of the
antispasmodic, anxiolytic and antidepressant effects of extracts
obtained from the leaves of S. lentiscifolius. Several species of the
genus Schinus are used popularly in pathologies such as intestinal
spasms.5 However, there are only reports on the antispasmodic6
properties of S. terebinthifolius.31 Our experimental results showed
that SchT has antispasmodic effect given that it inhibited in a non-
competitive way the cholinergic contraction and the blockade of
calcium influx via calcium channels in rat intestine, bladder and
uterus. Likewise, many reports showed similar results for other
medicinal plants.15,35 In the intestinal muscle alone, the IC50 on
Table 2
Spontaneous locomotion of mice measured as the number of crossed lines in 5 min produced by Schinus lentiscifolius extracts.
Treatment 0 min 30 min 60 min 90 min 120 min
Vehicle (saline) (n ¼ 8) 141.88 ± 9.10 105.12 ± 12.73 87.25 ± 8.73 77.87 ± 11.03 65.25 ± 11.58
Diazepam 1 mg/kg (n ¼ 9) 126.22 ± 11.02 61.00 ± 12.26 35.89 ± 6.70* 26.44 ± 4.03* 22.44 ± 4.88
SchW 200 mg/kg (n ¼ 6) 152.33 ± 9.29 128.00 ± 13.74# 85.50 ± 11.66 67.17 ± 9.55 59.83 ± 10.68
SchW 400 mg/kg (n ¼ 6) 154.50 ± 9.67 128.00 ± 7.75# 100.17 ± 12.02# 88.50 ± 10.01# 79.33 ± 9.16#
Vehicle (ethanol 70 % v/v) (n ¼ 9) 146.66 ± 14.63 72.22 ± 22.21 37.78 ± 10.21* 21.67 ± 8.96* 19.78 ± 8.32
SchT 30 mg/kg (n ¼ 6) 113.17 ± 8.36 69.89 ± 11.11 58.33 ± 9.00* 52.00 ± 5.72 53.55 ± 7.40
SchT 100 mg/kg (n ¼ 15) 154.5 ± 9.67 128.00 ± 7.75 100.17 ± 12.02 88.50 ± 10.01 79.33 ± 9.16
Vehicle (DMSO) (n ¼ 6) 118.17 ± 2.02 84.47 ± 2.99 87.83 ± 2.99# 85.67 ± 2.90# 103.50 ± 1.87#
SchO 10 mg/kg (n ¼ 6) 120.88 ± 6.96 27.0 ± 13.05* a 12.50 ± 3.42*a 14.33 ± 2.23*a 11.00 ± 3.25*a
SchO 30 mg/kg (n ¼ 6) 122.20 ± 14.04 5.60 ± 1.47*#a 7.40 ± 3.01*a 12.60 ± 5.02*a 10.60 ± 1.83a












*p < 0.05 vs vehicle (saline); #p < 0.05 vs diazepam and a vs respective vehicle by a posteriori Tukey's tests.
C. Vanegas Andrade, S. Matera, M. Bayley et al. Journal of Traditional and Complementary Medicine xxx (xxxx) xxxCCR-CCh was significantly higher than the IC50 on CCR-Ca2þ
(*p < 0.05; t-test: t ¼ 3.250, df ¼ 10), suggesting that the effect of
SchT on this muscle involves a more sensitive pathway to affect the
calcium influx than that derived from the muscarinic receptor
activation. Since the spasmolytic effect of S. terebinthifolius could be
associated with an antihistaminic effect,31 we evaluated whether
SchT has the same pattern. However, SchT inhibited the histamine-
induced contraction in a non-competitive way on guinea-pig ileum.
Also, we show that SchT does not block the serotonin and oxytocin
receptors in the uterus because it reduced non-competitively the
contraction produced by these agonists.
The presence of isoquercetin and rutin was demonstrated in
SchT by HPLC-UV. While rutin had no significant effect on
contracture of isolated rat ileum, isoquercetin decreased the phasic
and tonic contractions in the same tissue.22 Therefore, isoquercetin
could be one of the components responsible for the effect of SchT
on the intestine. Regarding the presence of flavonoids in SchT, there
are several articles about its relaxant effects, not only in rat intes-
tine35 but also in uterus37 and bladder.18 In fact, it has been found
that flavonoids effect involves multiple pathways, mainly the non-
competitive muscarinic antagonism and competitive inhibition of
Ca2þ channels.12 Also, SchT exhibited in the Ca2þ-CRC of the in-
testine a pattern similar to verapamil, a calcium channels blocker.7
In addition, verapamil also showed a non-competitive effect on
cholinergic and oxytocin contractions in isolated rat uterus,2 as well
as SchT does. Therefore, the inhibition of calcium influx could be
behind the antispasmodic effect of SchT in rat isolated bladder,
intestine and uterus, and even in other smooth muscles. Besides,
this effect is in agreement with the traditional use of S. molle or S.
terebinthifoliusfor gastrointestinal disorders and uterine inflam-
mation, respectively.1,41
Psychiatric disorders such as anxiety, insomnia and depression
have a high population prevalence. Despite efforts to treat these
disorders, the drugs commonly used have several side effects and
their effectiveness is discussed. Therefore, the research on medic-
inal plants with sedative, anxiolytic or antidepressant effects is a
promising field. In this regard, S. molle produces an antidepressant-
like effect on various systems, for instance on the dopaminergic,
noradrenergic and serotonergic pathways.29 In this case, we eval-
uated the effect on behavior of S. lentiscifolius extracts. As this plant
is popularly consumed as tea, we studied the central effects not
only of SchT, but also of leaf infusion (SchW). SchT and SchW did
not change either the spontaneous mobility or the grooming, but
they decreased rearing in the OFT. Our results discard a sedative
effect of SchT or SchW. By other side, the anxiolytic effect of both
extracts were evaluated using NFT. This test evaluate the anxiety-
related state in mice under basal conditions and following7
exposure to an acute stressor.30 A shorter FL in a food-deprived
animal caused by exposure to a potentially anxiogenic novel envi-
ronment is related with an anxiolytic effect.30 High doses of SchT
and SchW dropped the FL without changing home-cage con-
sumption in NFT. This effect of both extracts was reversed by flu-
mazenil, which suggests that a benzodiazepine-like effect is in fact
involved in this activity. Regarding the presence of rutin in SchT, we
found that this flavonoid also induced a decrease FL in NFT. Since
rutin exerts its anxiolytic effect by a mechanism that involves
GABAergic transmission but this effect was not reversed by flu-
mazenil,23 the effect of SchT in NFT should not only be due to the
presence of rutin. Thus, SchT and SchW showed to be effective in an
anxiolytic model without producing sedative effect, which is the
main side effect of classical anxiolytic drugs. This property agrees
with that of selective drugs linked to the a2 subunit of GABAA re-
ceptors, which display a similar pattern.10
Because NFT test does not provide information on putative ef-
fect on depressive-like behavior in acute stress,30 it was evaluated
by using the TST and FST tests. Both of them widely used to screen
new antidepressant drugs. These models are based on the appli-
cation of acute stress to the animal by restriction space.8,45 High
doses of SchT and SchW decreased the IT in TST and FST. The effect
of SchT in FST was less than the one found in TST when comparing
to clomipramine effect (see Figs. 5 and 6). A comparative study
provides supporting evidence on the difference in sensitivity of
both tests, probably due to the dissimilarities between patho-
physiological mechanisms.4 It has been previously reported that
drugs that stimulate locomotor activity can throw false-positives
results in both TST and FST.8 However, neither SchT nor SchW
increased spontaneous mobility in OFT, therefore these findings in
TST and FST support the antidepressant use of these extracts.
Essential oils exhibit several biological properties for the treat-
ment of central nervous system disorders.9 They are complex
mixtures of components including phenylpropanoids and volatile
terpenes.5 Moreover, the variability of their chemical composition
depends on the nature of the geographical distribution and it de-
fines the variety of biological effects.6 The SchO native of Argentina
was tested by GC-FID-MS and showed among its main components
a high proportion of D-limonene, a-santalol, b-caryophyllene and a-
pinene. D-limonene and a-santalol have been reported to have ef-
fects on behavior.16,36 SchO caused a decrease in spontaneous
mobility and rearing, similarly to diazepam in OFT. Also, it led to a
decrease in FL and home-cage consumption in NFT; these effects
were not reversed by flumazenil. These results confirm the sedative
and anxiolytic effects of SchO by a mechanism unrelated to that of
benzodiazepines. There are studies that provide evidence of the
anxiolytic-like effect of D-limonene; however, the mechanism
Fig. 4. Effects of Schinus lentiscifolius extracts (SchW, SchT and SchO) in comparisonwith the respective vehicle and diazepam (in a, b and c), rutin (a), and flumazenil (a, b, c) on feed
latency in novelty-suppressed feed test. One-way ANOVA: P < 0.001 (Table A5). A posteriori Tukey's test: *p < 0.05 vs vehicle, #p < 0.05 vs diazepam, @p < 0.05 vs
extract þ flumazenil (Fzl) (n ¼ 6e10 as indicated in each group).
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tion used.13,27 Regarding the presence of a-santalol in SchO, there
are several reports about its sedative effect.32,36 Thus, the compo-
nents identified in SchO may exert synergistic actions on the
behavior of mice. SchO also decreased the IT in TST, suggesting an8
antidepressant effect. Similar effects have also been reported for
the essential oil of S. terebinthifolius fruits,34 whereas components
present in SchO, such as D-limonene, b-caryophyllene and a-
pinene, have been reported for their antidepressant action.26,29 In
addition, since b-caryophyllene has shown a similar effect in TST
Fig. 5. Effects of Schinus lentiscifolius extracts (SchW in a, SchT in b and SchO in c) on duration of immobility tail suspension test. One-way ANOVA: P < 0.001 (Table A6). A posteriori
Tukey's test: *p < 0.05 vs vehicle, #p < 0.05 vs clomipramine (n ¼ 6e10, as indicated in each group).
C. Vanegas Andrade, S. Matera, M. Bayley et al. Journal of Traditional and Complementary Medicine xxx (xxxx) xxxand FST linked to action on the cannabinoid CB2 receptor,3 its
presence in SchO could contribute to its anxiolytic and
antidepressant-like effects. However additional research will be
necessary to probe this hypothesis and deep the mechanism
underlying.9
5. Conclusions
Our results demonstrate that the tincture obtained from
S. lentiscifolius leaves is effective as an intestinal, urinary and
uterine antispasmodic. These findings appear to be associated with
Fig. 6. Effects of Schinus lentiscifolius extracts (SchW in a, SchT in b) on duration of immobility in forced swimming test. One-way ANOVA: P < 0.001 (Table A7). A posteriori Tukey's
test: *p < 0.05 vs vehicle, #p < 0.05 vs clomipramine. (n ¼ 6 for all treatments).
C. Vanegas Andrade, S. Matera, M. Bayley et al. Journal of Traditional and Complementary Medicine xxx (xxxx) xxxthe presence of flavonoids, such as rutin and isoquercetin, both
identified in SchT. Moreover, its antispasmodic effect is mediated
by a mechanism that involves several pathways, mainly the non-
competitive antagonism of agonists and the non-competitive in-
hibition of Ca2þ channels with a pattern similar to verapamil.
Our results suggest that the tincture and infusion of
S. lentiscifolius have an anxiolytic effect similar to that of benzodi-
azepines, as well as an antidepressant-like effect, and that the
presence of rutin could be partly responsible for these. The essen-
tial oil showed similar effects and significantly reduced locomotor
activity in mice. D-limonene, a-santalol, b-caryophyllene and a-
pinene, its main components, may be involved in these actions.
However, to improve the knowledge of the mechanisms involved,
further research is required.
Thus, the present study contributes to the new knowledge on
the antispasmodic effects of S. lentiscifolius in urinary and uterine
tissues, as well as it reinforces the traditional use of this plant for
gastrointestinal and central depressive symptoms.Funding
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